Search Results 401-410 of 11934 for ���������������������������:za33���24������ ������������������������ ������
The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Rochester, Minnesota: 24-004117. NCT ID: NCT06402123. Sponsor Protocol Number: TIS6463-203. About this study. The purpose of this study is to evaluate the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.